{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T14:39:40Z","timestamp":1787755180457,"version":"build-2784847793"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T00:00:00Z","timestamp":1734652800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T00:00:00Z","timestamp":1734652800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. U1804195"],"award-info":[{"award-number":["No. U1804195"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-024-05869-2","type":"journal-article","created":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T12:17:58Z","timestamp":1734697078000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["ANGPTL4 mediated mesothelial-mesenchymal transition in pulmonary fibrosis: a potential therapeutic target"],"prefix":"10.1186","volume":"22","author":[{"given":"Yuechong","family":"Xia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyan","family":"Hui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songyun","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,20]]},"reference":[{"issue":"10082","key":"5869_CR1","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1016\/S0140-6736(17)30866-8","volume":"389","author":"L Richeldi","year":"2017","unstructured":"Richeldi L, Collard HR, Jones MG. Idiopathic pulmonary fibrosis. Lancet. 2017;389(10082):1941\u201352.","journal-title":"Lancet"},{"key":"5869_CR2","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/nrdp.2017.74","volume":"3","author":"FJ Martinez","year":"2017","unstructured":"Martinez FJ, Collard HR, Pardo A, Raghu G, Richeldi L, Selman M, et al. Idiopathic pulmonary fibrosis. Nat Rev Dis Primers. 2017;3:170\u20134.","journal-title":"Nat Rev Dis Primers"},{"issue":"5","key":"5869_CR3","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1097\/MCP.0b013e32832ea4b3","volume":"15","author":"SK Frankel","year":"2009","unstructured":"Frankel SK, Schwarz MI. Update in idiopathic pulmonary fibrosis. Curr Opin Pulm Med. 2009;15(5):463\u20139.","journal-title":"Curr Opin Pulm Med"},{"issue":"6","key":"5869_CR4","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.rmed.2015.02.002","volume":"109","author":"HJ Kim","year":"2015","unstructured":"Kim HJ, Perlman D, Tomic R. Natural history of idiopathic pulmonary fibrosis. Respir Med. 2015;109(6):661\u201370.","journal-title":"Respir Med"},{"key":"5869_CR5","doi-asserted-by":"publisher","first-page":"105803","DOI":"10.1016\/j.rmed.2019.105803","volume":"159","author":"S Cerri","year":"2019","unstructured":"Cerri S, Monari M, Guerrieri A, Donatelli P, Bassi I, Garuti M, et al. Real-life comparison of pirfenidone and nintedanib in patients with idiopathic pulmonary fibrosis: a 24-month assessment. Respir Med. 2019;159:105803.","journal-title":"Respir Med"},{"key":"5869_CR6","doi-asserted-by":"publisher","first-page":"797292","DOI":"10.3389\/fphar.2021.797292","volume":"12","author":"Q Mei","year":"2021","unstructured":"Mei Q, Liu Z, Zuo H, Yang Z, Qu J. Idiopathic pulmonary fibrosis: an update on pathogenesis. Front Pharmacol. 2021;12:797292.","journal-title":"Front Pharmacol"},{"issue":"1","key":"5869_CR7","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1002\/jcp.30500","volume":"237","author":"LL Zhou","year":"2022","unstructured":"Zhou LL, Cheng PP, He XL, Liang LM, Wang M, Lu YZ, et al. Pleural mesothelial cell migration into lung parenchyma by calpain contributes to idiopathic pulmonary fibrosis. J Cell Physiol. 2022;237(1):566\u201379.","journal-title":"J Cell Physiol"},{"issue":"6","key":"5869_CR8","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1164\/rccm.2009-040GL","volume":"183","author":"G Raghu","year":"2011","unstructured":"Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, et al. An official ATS\/ERS\/JRS\/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011;183(6):788\u2013824.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"5869_CR9","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1183\/09031936.00141010","volume":"39","author":"KK Mubarak","year":"2012","unstructured":"Mubarak KK, Montes-Worboys A, Regev D, Nasreen N, Mohammed KA, Faruqi I, et al. Parenchymal trafficking of pleural mesothelial cells in idiopathic pulmonary fibrosis. Eur Respir J. 2012;39(1):133\u201340.","journal-title":"Eur Respir J"},{"issue":"3","key":"5869_CR10","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.ymthe.2016.12.017","volume":"25","author":"Q Zhang","year":"2017","unstructured":"Zhang Q, Ye H, Xiang F, Song LJ, Zhou LL, Cai PC, et al. miR-18a-5p inhibits sub-pleural pulmonary fibrosis by targeting TGF-beta receptor II. Mol Ther. 2017;25(3):728\u201338.","journal-title":"Mol Ther"},{"issue":"1","key":"5869_CR11","doi-asserted-by":"publisher","first-page":"8251","DOI":"10.1038\/s41467-023-43900-0","volume":"14","author":"B Chaube","year":"2023","unstructured":"Chaube B, Citrin KM, Sahraei M, Singh AK, de Urturi DS, Ding W, et al. Suppression of angiopoietin-like 4 reprograms endothelial cell metabolism and inhibits angiogenesis. Nat Commun. 2023;14(1):8251.","journal-title":"Nat Commun"},{"issue":"8","key":"5869_CR12","doi-asserted-by":"publisher","first-page":"e11222","DOI":"10.15252\/emmm.201911222","volume":"12","author":"KH Jung","year":"2020","unstructured":"Jung KH, Son MK, Yan HH, Fang Z, Kim J, Kim SJ, et al. ANGPTL4 exacerbates pancreatitis by augmenting acinar cell injury through upregulation of C5a. EMBO Mol Med. 2020;12(8):e11222.","journal-title":"EMBO Mol Med"},{"key":"5869_CR13","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.125437","author":"DI Cho","year":"2019","unstructured":"Cho DI, Kang H-J, Jeon JH, Eom GH, Cho HH, Kim MR, et al. Antiinflammatory activity of ANGPTL4 facilitates macrophage polarization to induce cardiac repair. JCI Insight. 2019. https:\/\/doi.org\/10.1172\/jci.insight.125437.","journal-title":"JCI Insight"},{"issue":"5","key":"5869_CR14","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1164\/rccm.201712-2551OC","volume":"199","author":"A Prasse","year":"2019","unstructured":"Prasse A, Binder H, Schupp JC, Kayser G, Bargagli E, Jaeger B, et al. BAL cell gene expression is indicative of outcome and airway basal cell involvement in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2019;199(5):622\u201330.","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"5869_CR15","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1093\/bioinformatics\/bts034","volume":"28","author":"JT Leek","year":"2012","unstructured":"Leek JT, Johnson WE, Parker HS, Jaffe AE, Storey JD. The sva package for removing batch effects and other unwanted variation in high-throughput experiments. Bioinformatics. 2012;28(6):882\u20133.","journal-title":"Bioinformatics"},{"key":"5869_CR16","unstructured":"Single-cell RNA-seq reveals ectopic and aberrant lung-resident cell populations in idiopathic pulmonary fibrosis."},{"issue":"7","key":"5869_CR17","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1016\/j.cell.2019.05.031","volume":"177","author":"T Stuart","year":"2019","unstructured":"Stuart T, Butler A, Hoffman P, Hafemeister C, Papalexi E, Mauck WM 3rd, et al. Comprehensive integration of single-cell data. Cell. 2019;177(7):1888-902.e21.","journal-title":"Cell"},{"key":"5869_CR18","doi-asserted-by":"publisher","DOI":"10.1093\/jmcb\/mjae021","author":"P Yan","year":"2024","unstructured":"Yan P, Yang K, Xu M, Zhu M, Duan Y, Li W, et al. CCT6A alleviates pulmonary fibrosis by inhibiting HIF-1\u03b1-mediated lactate production. J Mol Cell Biol. 2024. https:\/\/doi.org\/10.1093\/jmcb\/mjae021.","journal-title":"J Mol Cell Biol"},{"key":"5869_CR19","first-page":"114","volume":"595","author":"L Franzen","year":"2024","unstructured":"Franzen L, Olsson Lindvall M, Huhn M, Ptasinski V, Setyo L, Keith BP, et al. Mapping spatially resolved transcriptomes in human and mouse pulmonary fibrosis. Nat Genet. 2024;595:114.","journal-title":"Nat Genet"},{"key":"5869_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-023-02349-z","author":"A Gul","year":"2023","unstructured":"Gul A, Yang F, Xie C, Du W, Mohammadtursun N, Wang B, et al. Pulmonary fibrosis model of mice induced by different administration methods of bleomycin. BMC Pulmon Med. 2023. https:\/\/doi.org\/10.1186\/s12890-023-02349-z.","journal-title":"BMC Pulmon Med"},{"issue":"1","key":"5869_CR21","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1186\/s12967-024-05289-2","volume":"22","author":"Z Sun","year":"2024","unstructured":"Sun Z, Ji Z, Meng H, He W, Li B, Pan X, et al. Lactate facilitated mitochondrial fission-derived ROS to promote pulmonary fibrosis via ERK\/DRP-1 signaling. J Transl Med. 2024;22(1):479.","journal-title":"J Transl Med"},{"key":"5869_CR22","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0053-2017","author":"SE Torrisi","year":"2017","unstructured":"Torrisi SE, Pavone M, Vancheri A, Vancheri C. When to start and when to stop antifibrotic therapies. Eur Respir Rev. 2017. https:\/\/doi.org\/10.1183\/16000617.0053-2017.","journal-title":"Eur Respir Rev"},{"issue":"1","key":"5869_CR23","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1186\/s12931-024-02898-9","volume":"25","author":"X Ju","year":"2024","unstructured":"Ju X, Wang K, Wang C, Zeng C, Wang Y, Yu J. Regulation of myofibroblast dedifferentiation in pulmonary fibrosis. Respir Res. 2024;25(1):284.","journal-title":"Respir Res"},{"issue":"4","key":"5869_CR24","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.biocel.2006.11.005","volume":"39","author":"RJ McAnulty","year":"2007","unstructured":"McAnulty RJ. Fibroblasts and myofibroblasts: their source, function and role in disease. Int J Biochem Cell Biol. 2007;39(4):666\u201371.","journal-title":"Int J Biochem Cell Biol"},{"issue":"1","key":"5869_CR25","doi-asserted-by":"publisher","first-page":"e2101235","DOI":"10.1002\/advs.202101235","volume":"9","author":"PC Tang","year":"2022","unstructured":"Tang PC, Chung JY, Xue VW, Xiao J, Meng XM, Huang XR, et al. Smad3 promotes cancer-associated fibroblasts generation via macrophage-myofibroblast transition. Adv Sci. 2022;9(1):e2101235.","journal-title":"Adv Sci"},{"issue":"9","key":"5869_CR26","doi-asserted-by":"publisher","first-page":"6043","DOI":"10.4049\/jimmunol.179.9.6043","volume":"179","author":"N Decologne","year":"2007","unstructured":"Decologne N, Kolb M, Margetts PJ, Menetrier F, Artur Y, Garrido C, et al. TGF-beta1 induces progressive pleural scarring and subpleural fibrosis. J Immunol. 2007;179(9):6043\u201351.","journal-title":"J Immunol"},{"issue":"31","key":"5869_CR27","doi-asserted-by":"publisher","first-page":"e242","DOI":"10.3346\/jkms.2023.38.e242","volume":"38","author":"G Loloci","year":"2023","unstructured":"Loloci G, Kim YM, Choi WI, Jang HJ, Park SJ, Kwon KY. Properties of pleural mesothelial cells in idiopathic pulmonary fibrosis and cryptogenic organizing pneumonia. J Korean Med Sci. 2023;38(31):e242.","journal-title":"J Korean Med Sci"},{"issue":"11","key":"5869_CR28","doi-asserted-by":"publisher","first-page":"L1305","DOI":"10.1152\/ajplung.00058.2015","volume":"309","author":"RM Kottmann","year":"2015","unstructured":"Kottmann RM, Trawick E, Judge JL, Wahl LA, Epa AP, Owens KM, et al. Pharmacologic inhibition of lactate production prevents myofibroblast differentiation. Am J Physiol-Lung Cel Mol Physiol. 2015;309(11):L1305\u201312.","journal-title":"Am J Physiol-Lung Cel Mol Physiol"},{"issue":"5","key":"5869_CR29","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1021\/acs.jproteome.6b00156","volume":"15","author":"YP Kang","year":"2016","unstructured":"Kang YP, Lee SB, Lee JM, Kim HM, Hong JY, Lee WJ, et al. Metabolic profiling regarding pathogenesis of idiopathic pulmonary fibrosis. J Proteome Res. 2016;15(5):1717\u201324.","journal-title":"J Proteome Res"},{"key":"5869_CR30","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.aay1027","author":"B Selvarajah","year":"2021","unstructured":"Selvarajah B, Azuelos I, Anastasiou D, Chambers RC. Fibrometabolism-An emerging therapeutic frontier in pulmonary fibrosis. Sci Signal. 2021. https:\/\/doi.org\/10.1126\/scisignal.aay1027.","journal-title":"Sci Signal"},{"key":"5869_CR31","doi-asserted-by":"publisher","first-page":"1379521","DOI":"10.3389\/fendo.2024.1379521","volume":"15","author":"Y Wang","year":"2024","unstructured":"Wang Y, Wang X, Du C, Wang Z, Wang J, Zhou N, et al. Glycolysis and beyond in glucose metabolism: exploring pulmonary fibrosis at the metabolic crossroads. Front Endocrinol. 2024;15:1379521.","journal-title":"Front Endocrinol"},{"issue":"1","key":"5869_CR32","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1165\/rcmb.2020-0360OC","volume":"64","author":"H Cui","year":"2021","unstructured":"Cui H, Xie N, Banerjee S, Ge J, Jiang D, Dey T, et al. Lung myofibroblasts promote macrophage profibrotic activity through lactate-induced histone lactylation. Am J Respir Cell Mol Biol. 2021;64(1):115\u201325.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"6","key":"5869_CR33","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1165\/rcmb.2019-0255OC","volume":"62","author":"M Saito","year":"2020","unstructured":"Saito M, Mitani A, Ishimori T, Miyashita N, Isago H, Mikami Y, et al. Active mTOR in lung epithelium promotes epithelial-mesenchymal transition and enhances lung fibrosis. Am J Respir Cell Mol Biol. 2020;62(6):699\u2013708.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"3","key":"5869_CR34","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1165\/rcmb.2022-0304OC","volume":"69","author":"S Saito","year":"2023","unstructured":"Saito S, Kitabatake M, Ouji-Sageshima N, Ogawa T, Oda A, Nishimura T, et al. Angiopoietin-like 4 is a critical regulator of fibroblasts during pulmonary fibrosis development. Am J Respir Cell Mol Biol. 2023;69(3):328\u201339.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"5","key":"5869_CR35","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.celrep.2015.01.011","volume":"10","author":"L Li","year":"2015","unstructured":"Li L, Chong HC, Ng SY, Kwok KW, Teo Z, Tan EHP, et al. Angiopoietin-like 4 increases pulmonary tissue leakiness and damage during influenza pneumonia. Cell Rep. 2015;10(5):654\u201363.","journal-title":"Cell Rep"},{"key":"5869_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12093271","author":"O Pizano-Martinez","year":"2023","unstructured":"Pizano-Martinez O, Mendieta-Condado E, V\u00e1zquez-Del Mercado M, Mart\u00ednez-Garc\u00eda EA, Chavarria-Avila E, Ortu\u00f1o-Sahag\u00fan D, et al. Anti-drug antibodies in the biological therapy of autoimmune rheumatic diseases. J Clin Med. 2023. https:\/\/doi.org\/10.3390\/jcm12093271.","journal-title":"J Clin Med"},{"issue":"2","key":"5869_CR37","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/s41584-020-00540-8","volume":"17","author":"V Strand","year":"2021","unstructured":"Strand V, Goncalves J, Isaacs JD. Immunogenicity of biologic agents in rheumatology. Nat Rev Rheumatol. 2021;17(2):81\u201397.","journal-title":"Nat Rev Rheumatol"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-024-05869-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-024-05869-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-024-05869-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T13:03:52Z","timestamp":1734699832000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-024-05869-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,20]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["5869"],"URL":"https:\/\/doi.org\/10.1186\/s12967-024-05869-2","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,20]]},"assertion":[{"value":"9 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The animal study was reviewed and approved by the Ethics Committee of the First Affiliated Hospital of Xinxiang Medical University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1114"}}